LA Private

Uncategorized

Mid-Year Economic and Fiscal Outlook (MYEFO) – deficits, high spending making things hard for RBA

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses the Mid-Year Economic and Fiscal Outlook. Key points: The Federal Government’s Mid-Year Economic and Fiscal Outlook (MYEFO) confirms a return to budget deficit this year and has revised up its deficit projections sharply reflecting increased spending in existing programs, less corporate tax

Mid-Year Economic and Fiscal Outlook (MYEFO) – deficits, high spending making things hard for RBA Read More »

Dotz Nano secures first commercial sale of DotzShield in the US

Dotz Nano (ASX:DTZ) has secured the first commercial order for the company’s DotzShield tagging solution from a major US-based provider of oilfield technology services. The deal is valued at approximately $340,000. DotzShield allows for real-time detection and dosage management of corrosion inhibitors used in the oil and gas industry. Traditionally, detecting and quantifying corrosion inhibitors

Dotz Nano secures first commercial sale of DotzShield in the US Read More »

Lionheart roars: Vulcan seals 879m euros in project funding

Vulcan Energy (ASX:VUL) has signed a conditional debt commitment letter for €879m (about A$1.45bn) to fund Phase One of its Lionheart Project. The agreement is backed by Export Finance Australia (EFA) and a syndicate of seven commercial banks. Lionheart is a major lithium and renewable energy initiative located in the Upper Rhine Valley Brine Field,

Lionheart roars: Vulcan seals 879m euros in project funding Read More »

Mineral Resources completes $780m gas sale to Hancock Prospecting

Mineral Resources (ASX:MIN) has finalised the sale of 100% of its interest in Exploration Permits 368 and 426 to Hancock Prospecting for an initial payment of $780m. In addition to the sale, Mineral Resources and Hancock Prospecting have agreed to form two 50/50 joint ventures over Mineral Resources’ remaining exploration permits in the Perth and

Mineral Resources completes $780m gas sale to Hancock Prospecting Read More »

Clarity’s new “pan-cancer” radiopharmaceutical

Clarity Pharmaceuticals (ASX:CU6) has expanded its cancer treatment pipeline with the development of a novel radiopharmaceutical called “SAR-bisFAP”. This new product is designed for both diagnosis and treatment, and has possible “pan-cancer opportunity”. What’s in a name? Radiopharmaceuticals combine two components: a radioactive isotope and a targeting molecule. The targeting molecule directs the isotope to

Clarity’s new “pan-cancer” radiopharmaceutical Read More »

Insignia rejects Bain Capital

Insignia Financial (ASX:IFL) has rejected a non-binding, indicative takeover proposal from Bain Capital, saying that the offer did not reflect the company’s fundamental value. The proposal, announced on 13 December 2024, sought to acquire 100% of Insignia’s shares via a scheme of arrangement. Insignia’s board, after consulting with financial advisers Citigroup and Gresham Advisory Partners,

Insignia rejects Bain Capital Read More »